Personalized Medicine in Ovarian Cancer: A Perspective From Mexico

Fernández Garza, Luis E. y Domínguez Vigil, Irma G. y Garza Martínez, José y Valdez Aparicio, Erick A. y Barrera Barrera, Silvia A. y Barrera Saldaña, Hugo A. (2021) Personalized Medicine in Ovarian Cancer: A Perspective From Mexico. World Journal of Oncology, 12 (4). pp. 85-92. ISSN 1920-4531

Texto
27187.pdf.crdownload - Versión Publicada
Available under License Creative Commons Attribution Non-commercial No Derivatives.
Download (1MB)

Resumen

Ovarian cancer (OC) represents a serious health problem worldwide. In Mexico, most OC patients are detected at late stages, consequently making OC one of the leading causes of death in women after reaching puberty. Personalized medicine (PM) provides an individualized therapeutic opportunity for treating each patient relying on “omic” tools to match the correct drug with the specific pathogenic genomic signature. PM can help predict the best therapeutic option for each affected woman suffering from OC. In recent years, Mexico has made contributions to the PM of OC; however, it still has a long way to go for its full implementation in the country’s health system.

Tipo de elemento:

Article

Palabras claves no controlados:

Medicina personalizada; Cáncer de ovarios; Terapias dirigidas; México

Materias:

R Medicina > RG Ginecología y Obstetricia

Divisiones:

Medicina

Usuario depositante:

Dr Irma G Dominguez Vigil

Creadores:

Creador	Email	ORCID
Fernández Garza, Luis E.	luisfdz12@gmail.com	orcid.org/0000-0003-2387-4643
Domínguez Vigil, Irma G.	irma52vigil@gmail.com	orcid.org/0000-0003-4687-6318
Garza Martínez, José	NO ESPECIFICADO	NO ESPECIFICADO
Valdez Aparicio, Erick A.	NO ESPECIFICADO	NO ESPECIFICADO
Barrera Barrera, Silvia A.	NO ESPECIFICADO	NO ESPECIFICADO
Barrera Saldaña, Hugo A.	habarrera@gmail.com	orcid.org/0000-0003-1587-4571